The drug, which costs roughly 29p per tablet, was trialled on nearly 741 people who tested positive within seven days and had underlying health conditions. Patients were given a daily course of two pills for 10 days. Of those given the medication, 79 (10.6 per cent) needed hospital care compared to 15.7 per cent in the placebo group. Writing in the paper, the researchers said their analysis showed the pills cut the risk of hospitalisation by 32 per cent. Fluvoxamine works by boosting the amount of serotonin in the brain, which can help to boost someone's mood. But the hormone...